Country Garden to Make Disposal to Aid Debt Restructuring
Chinese property giant Country Garden will sell a stake in a commercial center operator for about $428 million, using the proceeds to help restructure offshore debt.
Easing Food Prices Are Great News for Shoppers, but Bad News for Staples Stocks
the food at home consumer price index reading slowed for the 15th consecutive month last month, edging up just 1.7% from the year-ago period.
GM Cruise Executives Leave After October Crash
Nine staffers departing the driverless-car unit include the chief operating officer and its head of legal and policy.
Adobe Says Significant Costs, Penalties May Arise Out of FTC Investigation
Adobe said it could face significant costs or penalties tied to a Federal Trade Commission probe into its disclosure and subscription cancellation practices.
Regis CEO Open to Joining Gold-Mining Deal Fray After Closing Hedge Book
Regis Resources’ chief executive is looking forward to the miner enjoying a cash-building phase following a period of heavy investment, but isn’t ruling out a return to the deal table.
Pembina Agrees to Acquire Enbridge’s Interests in Joint Ventures
The deal would see Pembina acquire all of Enbridge’s interests in the Alliance, Aux Sable and NRGreen joint ventures for an aggregate purchase price of about $2.3 billion.
Tesla Recalls Millions of Vehicles Amid Probe of Autopilot Crashes
U.S. auto-safety regulators are looking into crashes involving the driver-assistance technology.
Credit Suisse to Pay $10 Million After SEC Alleges Prohibited Underwriting, Advising
Credit Suisse Securities and two affiliated entities will pay more than $10 million to settle charges from the U.S. Securities and Exchange Commission that it allegedly provided certain prohibited services.
Once an Ozempic Skeptic, This Diet-Company Giant Has Changed Its Mind
Investment in telehealth provider LifeMD would give Medifast customers access to doctors who can prescribe the medications.
Pfizer Warns 2024 Revenue Could Fall
Pfizer said revenue could fall next year, weighed down by a continued slowdown in demand for the pharmaceutical company’s Covid-19 vaccine and related products.
Source: Dow Jones Newswires